21 May 2009
Immunization of recipient with donor immobilized non-dividing splenocytes significantly prolongs allogeneic heart survival
W Olszewski, M Moscicka, H DolezyczekAnn Transplant 2009; 14(1): 68-68 :: ID: 880448
Abstract
Background: On the contact of recipient with the donor, transplantation antigens evoke humoral and cellular rejection reaction. Blood transfusions, pregnancy and previous grafts may cross-reactively immunize recipient against donor antigens. In all the mentioned cases donor antigens are mainly supplied by "passenger cells". These cells colonize recipient lymphoid tissues and produce progenies. This enhances immune response and subsequently rejection. The question arises whether metabolically immobilized non-dividing (mummified) donor cells administered to recipient prior to transplantation may mitigate rejection reaction, presumably by evoking formation of enhancing antibodies. Immobilisation can be achieved by treating the donor cells with pulverized NaCl. These cells retain their molecular structure but do not divide. Aim: to immunise recipient with donor NaCl-treated splenocytes prior to heart transplantation.
Material/Methods: BN rat spleen fragments were placed in pulverized NaCl and 7 d later implanted intraperitoneally into LEW rat on d 0 and 7. Seven days later heart TX from BN was performed. Non-immunized rats served as controls. No immunosuppression was given.
Results: the immunised LEW did not reject BN heart until d 20 (20±2),
whereas control rats rejected the graft within 6±1 days (p<0.001). Histology
showed that rejected hearts from immunised recipients' revealed hypertrophied muscle with few infiltrates, in contrast to controls with dense infiltrates and necrotic areas. Deposition of IgG in graft vessels could be seen on immunohistochemical pictures.
Conclusions: Immunisation of recipient with mummified splenocytes retaining their molecular structure may be responsible for prolongation of allogeneic heart survival.
Keywords: Heart Transplantation, Immunosuppression, Tissue Transplantation
In Press
Original article
Diagnostic Utility of FAR1 Methylation Levels in Hepatocellular Carcinoma Patients Undergoing Liver Transpl...Ann Transplant In Press; DOI: 10.12659/AOT.951568
Original article
Inferior Long-Term Outcome of Fatty Liver Allografts After Orthotopic Liver TransplantationAnn Transplant In Press; DOI: 10.12659/AOT.950589
Database Analysis
Identification and Validation of Liver Transplantation-Induced Acute Lung Injury Biomarkers Using a Bioinfo...Ann Transplant In Press; DOI: 10.12659/AOT.950289
Original article
Survival and Recurrence in Liver Transplant Patients With Intrahepatic Cholangiocarcinoma and Hepatocellula...Ann Transplant In Press; DOI: 10.12659/AOT.950997
Most Viewed Current Articles
24 Aug 2021 : Review article 18,372
Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future PerspectivesDOI :10.12659/AOT.931664
Ann Transplant 2021; 26:e931664
05 Apr 2022 : Original article 14,731
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
22 Nov 2022 : Original article 14,244
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
29 Dec 2021 : Original article 13,752
Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...DOI :10.12659/AOT.933588
Ann Transplant 2021; 26:e933588






